267 related articles for article (PubMed ID: 8682288)
1. [Paraneoplastic cerebellar degeneration: case report of a patient with breast carcinoma].
Huober J; Niedermaier N; Drlicek M; Kaufmann M; Hacke W; Bastert G
Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):214-6. PubMed ID: 8682288
[TBL] [Abstract][Full Text] [Related]
2. [61-year-old patient with rapidly progressive cerebellar symptoms].
Becker K; Wurster U; Kienast K; Fischer B
Pneumologie; 1995 Dec; 49(12):700-3. PubMed ID: 8584543
[TBL] [Abstract][Full Text] [Related]
3. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
Tanaka K; Tanaka M; Onodera O; Tsuji S
Rinsho Shinkeigaku; 1995 Jul; 35(7):770-4. PubMed ID: 8777801
[TBL] [Abstract][Full Text] [Related]
4. Paraneoplastic cerebellar degeneration: clinical-immunological correlations.
Anderson NE; Rosenblum MK; Posner JB
Ann Neurol; 1988 Oct; 24(4):559-67. PubMed ID: 3239956
[TBL] [Abstract][Full Text] [Related]
5. [Paraneoplastic cerebellar degeneration].
Chabriat H; Chen QM; Poisson M; Delattre JY
Rev Neurol (Paris); 1994; 150(2):105-14. PubMed ID: 7863150
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic neurological syndrome: patient with anti-Yo antibody and breast cancer: a case report.
Dorn C; Knobloch C; Kupka M; Morakkabati-Spitz N; Schmolling J
Arch Gynecol Obstet; 2003 Nov; 269(1):62-5. PubMed ID: 14605824
[TBL] [Abstract][Full Text] [Related]
7. [Paraneoplastic cerebellar degeneration (PCD) with anti-Yo antibodies in ovarian carcinoma].
Holzmann P; Holy D; Stillhard G; Janda M; Möbr P
Schweiz Med Wochenschr; 1998 Jun; 128(23):906-8. PubMed ID: 9658519
[TBL] [Abstract][Full Text] [Related]
8. [Importance of plasmapheresis in the treatment of paraneoplastic cerebellar degeneration].
Basić-Jukić N; Kes P; Basić-Kes V; Brunetta B
Acta Med Croatica; 2004; 58(1):63-6. PubMed ID: 15125396
[TBL] [Abstract][Full Text] [Related]
9. Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 2. Passive transfer of murine mononuclear cells activated with recombinant Yo protein to paraneoplastic cerebellar degeneration lymphocytes in severe combined immunodeficiency mice.
Tanaka K; Tanaka M; Igarashi S; Onodera O; Miyatake T; Tsuji S
Clin Neurol Neurosurg; 1995 Feb; 97(1):101-5. PubMed ID: 7788964
[TBL] [Abstract][Full Text] [Related]
10. [Subacute paraneoplastic cerebellar degeneration with anti-neuronal antibodies and gynecological cancers. A case report of a bilateral ovarian cancer where the classic "anti-YO" antibody is associated with another antineuronal antibody].
Tremouilhac C; Hamy A; De Ferron E; Paineau J; Visset J
J Gynecol Obstet Biol Reprod (Paris); 1996; 25(3):253-6. PubMed ID: 8767221
[TBL] [Abstract][Full Text] [Related]
11. [Paraneoplastic cerebellar degeneration. A case report].
Storstein A; Vedeler C; Krossnes B; Mørk S
Tidsskr Nor Laegeforen; 1997 Aug; 117(20):2947-8. PubMed ID: 9340852
[TBL] [Abstract][Full Text] [Related]
12. [Autoimmune paraneoplastic cerebellar degeneration].
Lövblad KO; Henny C; Boucraut J; Graus F; Delaloye JF; Bernard D; Steck AJ; Regli F
Rev Neurol (Paris); 1994; 150(1):46-9. PubMed ID: 7801040
[TBL] [Abstract][Full Text] [Related]
13. Paraneoplastic cerebellar degeneration: successful early detection and treatment of cancer through characterization of the anti-Purkinje cell antibody.
Tanaka K; Igarashi S; Yamazaki M; Nakajima T; Miyatake T; Sakai K
Intern Med; 1992 Dec; 31(12):1339-42. PubMed ID: 1300168
[TBL] [Abstract][Full Text] [Related]
14. [Paraneoplastic cerebellar degeneration].
Nakano R; Sato S
Nihon Rinsho; 1994 Nov; 52(11):3000-5. PubMed ID: 7996701
[TBL] [Abstract][Full Text] [Related]
15. Anti-Ri-associated paraneoplastic cerebellar degeneration and breast cancer: an autopsy case study.
Brieva-Ruíz L; Diaz-Hurtado M; Matias-Guiu X; Márquez-Medina D; Tarragona J; Graus F
Clin Neurol Neurosurg; 2008 Dec; 110(10):1044-6. PubMed ID: 18701208
[TBL] [Abstract][Full Text] [Related]
16. [A case of paraneoplastic cerebellar degeneration--success in early detection of cancer by anti-Purkinje cell antibody].
Igarashi S; Tanaka K; Nakajima T; Yamazaki M; Inuzuka T; Miyatake T
Rinsho Shinkeigaku; 1992 Mar; 32(3):309-13. PubMed ID: 1628454
[TBL] [Abstract][Full Text] [Related]
17. Paraneoplastic cerebellar degeneration with anti-Yo antibody in a patient with HER2/neu overexpressing breast cancer: a case report with a current literature review.
Ogita S; Llaguna OH; Feldman SM; Blum R
Breast J; 2008; 14(4):382-4. PubMed ID: 18540952
[TBL] [Abstract][Full Text] [Related]
18. Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degeneration.
Furneaux HM; Rosenblum MK; Dalmau J; Wong E; Woodruff P; Graus F; Posner JB
N Engl J Med; 1990 Jun; 322(26):1844-51. PubMed ID: 2348838
[TBL] [Abstract][Full Text] [Related]
19. Failure to detect cytotoxic T cell activity against recombinant Yo protein using autologous dendritic cells as the target in a patient with paraneoplastic cerebellar degeneration and anti-Yo antibody.
Tanaka M; Tanaka K; Idezuka J; Tsuji S
Exp Neurol; 1998 Apr; 150(2):337-8. PubMed ID: 9527904
[TBL] [Abstract][Full Text] [Related]
20. [The detection of anti-Purkinje cell antibody (anti-Yo antibody) by ELISA using recombinant Yo fusion protein].
Tanaka K; Tanaka M; Onodera O; Igarashi S; Tsuji S
No To Shinkei; 1994 Jan; 46(1):47-51. PubMed ID: 8136199
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
